- Home
- RSLS vs IMTE Comparison
RSLS vs IMTE Comparison
Compare RSLS & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- IMTE
- Stock Information
- Founded
- RSLS 2002
- IMTE 2008
- Country
- RSLS United States
- IMTE Malaysia
- Employees
- RSLS N/A
- IMTE N/A
- Industry
- RSLS Medical/Dental Instruments
- IMTE Consumer Electronics/Appliances
- Sector
- RSLS Health Care
- IMTE Consumer Staples
- Exchange
- RSLS Nasdaq
- IMTE Nasdaq
- Market Cap
- RSLS 4.5M
- IMTE 4.1M
- IPO Year
- RSLS 2007
- IMTE N/A
- Fundamental
- Price
- RSLS $2.39
- IMTE $1.06
- Analyst Decision
- RSLS Hold
- IMTE
- Analyst Count
- RSLS 1
- IMTE 0
- Target Price
- RSLS N/A
- IMTE N/A
- AVG Volume (30 Days)
- RSLS 4.4M
- IMTE 76.2K
- Earning Date
- RSLS 08-13-2025
- IMTE 07-22-2025
- Dividend Yield
- RSLS N/A
- IMTE N/A
- EPS Growth
- RSLS N/A
- IMTE N/A
- EPS
- RSLS N/A
- IMTE N/A
- Revenue
- RSLS $7,175,000.00
- IMTE $123,337.00
- Revenue This Year
- RSLS $52.80
- IMTE N/A
- Revenue Next Year
- RSLS N/A
- IMTE N/A
- P/E Ratio
- RSLS N/A
- IMTE N/A
- Revenue Growth
- RSLS N/A
- IMTE 4.75
- 52 Week Low
- RSLS $2.23
- IMTE $0.51
- 52 Week High
- RSLS $347.86
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- RSLS 38.10
- IMTE 47.89
- Support Level
- RSLS $2.37
- IMTE $1.00
- Resistance Level
- RSLS $2.73
- IMTE $1.13
- Average True Range (ATR)
- RSLS 0.17
- IMTE 0.10
- MACD
- RSLS 0.21
- IMTE 0.01
- Stochastic Oscillator
- RSLS 13.33
- IMTE 69.33
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.